Centinel Spine’s prodisc C Nova Makes its U.S. Surgical Debut

Centinel Spine LLC is marking the first U.S. implantation of its prodisc C Nova cervical total disc replacement (TDR) product, a device approved by the U.S. Food and Drug Administration two years ago for 1-level indications.

prodisc C Nova is Centinel Spine’s fourth cervical TDR offering, and the third new cervical TDR product the company has released in the United States since late 2022. The prodisc C Vivo and prodisc C SK products were both made available on a limited basis in late 2022 and have been used in more than 8,000 procedures since then. Along with the originally available prodisc C cervical implant—launched in the United States in 2007—Centinel Spine claims to possess the world’s widest offering of cervical TDR solutions to address surgeon preference and individual patient anatomy.

“The prodisc C Nova procedure went extremely well. The implant was easy to use and I believe it will serve this and many other patients very well,” said Dr. J. Alex Sielatycki of Steamboat Springs, Colo.-based Steamboat Orthopedic & Spine Institute. “The tri-keel tracked nicely and allowed me to ensure good positioning of the implant. I also believe the initial fixation will be strong enough to allow this and other patients to return to full activity quickly. The prodisc C Nova implant will be a nice complement to the prodisc match-the-disc system, which provides the surgeon even more versatility when performing cervical disc replacement across the spectrum of patients with differing anatomy and pathology. I believe this patient and many more to come will benefit greatly from this technology.”

prodisc C Nova was co-developed by spine surgeon and Pro-Spine Chairman/CEO Prof. Dr. Rudolf Bertagnoli in Straubing, Germany. First implanted in Europe in 2009, the device features tri-keel design and flat endplates for optimized implant positioning that allows surgeons to address individual patient anatomy. The low-profile keels enable a streamlined keel preparation technique and provide immediate fixation.

“prodisc C Nova has been my preferred cervical total disc replacement implant for many years,” Bertagnoli stated. “Its unique three-keel design, combined with the reliable prodisc motion mechanism, makes the prodisc C Nova particularly effective in my experience. The availability of a variety of anatomically-customized prodisc cervical endplates tailored to each patient offers substantial benefits for both surgeons and patients. With the introduction of the prodisc C Nova, these options are now further expanded for surgeons in the United States.”

The prodisc C Nova device incorporates prodisc CORE technology, the basis behind the predictable clinical outcomes of the prodisc platform after 30 years and more than 250,000 implantations worldwide.*

“We are delighted to make another proven prodisc cervical option available in the U.S. Our experience with prodisc C Vivo and prodisc C SK has shown that surgeons appreciate the variety of endplate designs for their consideration and selection in treating each patient,” Centinel Spine CEO Steve Murray noted. “And, importantly, the entire prodisc portfolio is built on the proven, safe, and reliable motion preservation design that makes prodisc such a trusted name in spine care. We are the only spine company exclusively focused on motion preservation, and prodisc C Nova further amplifies this commitment.”

Centinel Spine is exclusively focused on addressing cervical and lumbar spinal disease with prodisc technology—the most studied and clinically-proven TDR system worldwide, validated by over 540 published papers and more than 250,000 implantations. prodisc is reportedly the only TDR technology with multiple motion-preserving anatomic solutions, allowing the surgeon to Match-the-Disc to each patient’s anatomy for both cervical and lumbar total disc replacement.

* Data on file.